UB Paderborn / Katalog / Suche / in CDI

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

International journal of cancer, 2019-09, Vol.145 (6), p.1609-1624

2019

Link zum Volltext

Verfügbarkeit prüfen

Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR

International journal of cancer, 2023-07, Vol.153 (2), p.352-363

2023

Link zum Volltext

Verfügbarkeit prüfen

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

Cancer letters, 2017-08, Vol.402, p.190-202

2017

Link zum Volltext

Verfügbarkeit prüfen

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Oncotarget, 2016-03, Vol.7 (11), p.12404-12413

2016

Link zum Volltext

Verfügbarkeit prüfen

Orphan GRB Afterglow Searches with the Pan-STARRS1 COSMOS Survey

The Astrophysical journal, 2020-07, Vol.897 (1), p.69

2020

Link zum Volltext

Verfügbarkeit prüfen

Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

PloS one, 2015-05, Vol.10 (5), p.e0123305-e0123305

2015

Link zum Volltext

Verfügbarkeit prüfen

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

Journal of biomedical science, 2023-09, Vol.30 (1), p.1-80, Article 80

2023

Link zum Volltext

Verfügbarkeit prüfen

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

Cancer medicine (Malden, MA), 2023-07, Vol.12 (13), p.14511-14525

2023

Link zum Volltext

Verfügbarkeit prüfen

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

American journal of respiratory and critical care medicine, 2011-04, Vol.183 (8), p.1071-1079

2011

Link zum Volltext

Verfügbarkeit prüfen

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Cancer letters, 2013-01, Vol.328 (1), p.144-151

2013

Link zum Volltext

Verfügbarkeit prüfen

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

Molecular therapy. Nucleic acids, 2020-12, Vol.22, p.471-483

2020

Link zum Volltext

Verfügbarkeit prüfen

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Scientific reports, 2015-09, Vol.5 (1), p.13574-13574, Article 13574

2015

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer

Neoplasia (New York, N.Y.), 2018-08, Vol.20 (8), p.838-847

2018

Link zum Volltext

Verfügbarkeit prüfen

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

Cancer research (Chicago, Ill.), 2008-09, Vol.68 (18), p.7428-7438

2008

Link zum Volltext

Verfügbarkeit prüfen

Asteroid Discovery and Light Curve Extraction Using the Hough Transform: A Rotation Period Study for Subkilometer Main-belt Asteroids

The Astronomical journal, 2020-01, Vol.159 (1), p.25

2020

Link zum Volltext

Verfügbarkeit prüfen

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Oncotarget, 2015-04, Vol.6 (12), p.10415-10431

2015

Link zum Volltext

Verfügbarkeit prüfen

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Cancer biomarkers : section A of Disease markers, 2020-01, Vol.28 (3), p.351

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression

Journal of clinical oncology, 2005-02, Vol.23 (5), p.953-964

2005

Link zum Volltext

Verfügbarkeit prüfen

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

Molecular therapy. Nucleic acids, 2024-03, Vol.35 (1), p.102091-102091, Article 102091

2024

Link zum Volltext

Verfügbarkeit prüfen

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction

PloS one, 2011-08, Vol.6 (8), p.e23303

2011

Link zum Volltext

Verfügbarkeit prüfen

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

Cancers, 2019-01, Vol.11 (1), p.36

2019

Link zum Volltext

Verfügbarkeit prüfen

Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer

The Journal of pathology, 2015-01, Vol.235 (1), p.50-64

2015

Link zum Volltext

Verfügbarkeit prüfen

Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

Clinical cancer research, 2005-11, Vol.11 (22), p.8070-8078

2005

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

International journal of cancer, 2006-02, Vol.118 (4), p.963-969

2006

Link zum Volltext

Verfügbarkeit prüfen

The authors respond to favorable outcomes of early conversion to shockable rhythm in OHCA patients

The American journal of emergency medicine, 2023-02, Vol.64, p.195-195

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Orphan GRB Afterglow Searches with the Pan-STARRS1 COSMOS Survey

Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor

ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

Asteroid Discovery and Light Curve Extraction Using the Hough Transform: A Rotation Period Study for Subkilometer Main-belt Asteroids

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process

Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression

miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer

Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

The authors respond to favorable outcomes of early conversion to shockable rhythm in OHCA patients

Suchergebnisse filtern